Stock To Watch: One Down, One To Go For Cytokinetics (CYTK)

Shares of Cytokinetics Inc. (CYTK) have gained more than 40 percent so far this month as the Company gears up for the second interim analysis in its GALACTIC-HF trial.

from RTT - Biotech https://ift.tt/32wZSOB
via IFTTT